Rituxan Side Effects Lawsuits
Rituxan May Cause Serious Skin Infections. Parker Waichman LLP is investigating potential lawsuits on behalf of patients who experienced severe skin reactions such as Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson syndrome (SJS) after using Rituxan (rituximab). Rituxan is an intravenous medication used to treat cancer in the … [Read more...] about Rituxan Side Effects Lawsuits
Rituxan Side Effects Could Result In Brain Disease Lawsuits
Rituxan May Cause Brain Disease. On December 19, 2006 Genentech issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked to the deaths of two lupus patients from a rare brain disease, called Progressive multifocal leukoencephalopathy (PML). On November 10, 2006, Health … [Read more...] about Rituxan Side Effects Could Result In Brain Disease Lawsuits
Third Rituxan Patient Diagnosed with PML
Rituxan Patient Diagnosed with PML A third Rituxan patient has developed a serious and often fatal brain infection called progressive multifocal leukoencephalopathy (PML). According to a statement posted on the Food & Drug Administration (FDA) Web site, this is the first case of PML in a patient with rheumatoid arthritis treated … [Read more...] about Third Rituxan Patient Diagnosed with PML
Rituxan – PML Link Could Spark FDA Action
Regulators Are Taking a Look At The Link Between Rituxan And PML. U.S. health regulators are taking a look at the lymphoma drug Rituxan because of its possible association with progressive multifocal leukoencephalitis (PML), an often fatal brain infection. According to The Wall Street Journal, the Food & Drug Administration … [Read more...] about Rituxan – PML Link Could Spark FDA Action
Study Finds 57 Rituxan Patients Developed PML
Patients Taking Rituxan May Be At Risk. Patients taking Rituxan may be at risk of developing a serious, and often fatal brain infection called progressive multifocal leukoencephalitis (PML), according to the findings of a new study. The study, published in the journal Blood, reports on 57 cases of PML that developed in … [Read more...] about Study Finds 57 Rituxan Patients Developed PML
Rituxan warning issued by FDA
Patients Treated With Rituxan Are at Risk From Brain Infection. Patients treated with Rituxan may be at risk from a rare, fatal brain infection, the U.S. Food and Drug Administration warned Monday. The FDA said it has recently learned of two deaths from progresive multifocal leukoencephalopathy (PML) in patients treated with … [Read more...] about Rituxan warning issued by FDA
Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy
FDA is Warning Healthcare Professionals Regarding the Risk for PML Patients Receiving Rituxan. The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML) in patients receiving rituximab intravenous infusion (Rituxan, made by Genentech, Inc, and … [Read more...] about Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy
Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients
Patients Treated With Rituxan (Rituximab) Have Died. Two patients treated with the immune modulator Rituxan (rituximab) for systemic lupus erythmatosus (SLE) have died of progressive multifocal leukoencephalopathy (PML), the FDA warned physicians. The FDA said that PML, a viral infection of the central nervous system, has been … [Read more...] about Rituxan (rituxamab) Linked to Two Deaths in Lupus Patients
Biogen, Genentech issue warning for Rituxan
Biogen Idec and Genetech Issued A Warning About The Drug Rituxan. Biogen Idec and Genentech have issued a warning to healthcare providers for their oncology drug Rituxan, advising them that the drug has been linked to the deaths of two lupus patients from a rare brain disease. According to an advisory sent out by the Food and Drug … [Read more...] about Biogen, Genentech issue warning for Rituxan
FDA Warns of Severe Side Effects Associated with Rituxan
FDA Issued An Alert About Side Effects Associated with Rituxan. In an alert issued today, the U.S. Food and Drug Administration connected Rituxan with a fatal viral infection of the central nervous system. According to the FDA, two ‘Rituxan’ patients have died after developing progressive multifocal leukoencephalopathy … [Read more...] about FDA Warns of Severe Side Effects Associated with Rituxan
FDA issues alert on Genentech drug
Safety Information From Genentech Drug. Government health officials said Monday they are seeking additional safety information from Genentech Inc. on Rituxan following reports that two patients died while taking the drug, which is used to treat non-Hodgkins lymphoma and other conditions. The Food and Drug Administration said it … [Read more...] about FDA issues alert on Genentech drug
FDA ALERT
The FDA Alert Is About The Safety Information Of Drug Rituxan. This Alert highlights important emerging safety information about Rituxan. Two patients have died after being treated with Rituxan for systemic lupus erythematosus (SLE). The cause of death was a viral infection of the brain called progressive multifocal … [Read more...] about FDA ALERT
Rituxan (Rituximab) – Life-Threatening Brain Infection
FDA And Genentech Warned The Public About Rituxan (Rituximab). FDA and Genentech informed healthcare professionals of important emerging safety information about Rituxan. Two patients died after being treated with ‘Rituxan’ for systemic lupus erythematosus (SLE). ‘Rituxan’ is approved for the above indication and is … [Read more...] about Rituxan (Rituximab) – Life-Threatening Brain Infection
